Top compounds associated with response to UBE2F-SCLY


Feature Type Standardized
Nominal ANOVA
mRNA nintedanib CTRPv2 pan-cancer AAC -0.0013 1
mRNA MI-1 CTRPv2 pan-cancer AAC -0.0013 1
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0011 1
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.00068 1
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.0004 1
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.00026 1
mRNA erastin CTRPv2 pan-cancer AAC 0.00023 1
mRNA JW-480 CTRPv2 pan-cancer AAC 0.00023 1
mRNA lapatinib CTRPv2 pan-cancer AAC 0.00014 1
mRNA Tamoxifen CTRPv2 pan-cancer AAC 4.8e-05 1
Download CSV